These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34074288)

  • 1. The TBAg/PHA ratio in T-SPOT.TB assay has high prospective value in the diagnosis of active tuberculosis: a multicenter study in China.
    Liu Y; Yao L; Wang F; Sun Z; Tan Y; Sha W
    Respir Res; 2021 Jun; 22(1):165. PubMed ID: 34074288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The ratio of tuberculosis-specific antigen to phytohemagglutinin in T-SPOT assay in the diagnosis of active tuberculosis].
    Wang T; Tan YJ; Wu SJ; Huang M; Yin BT; Huang J; Wei N; Wei W; Wang F
    Zhonghua Jie He He Hu Xi Za Zhi; 2019 Apr; 42(4):262-267. PubMed ID: 30955283
    [No Abstract]   [Full Text] [Related]  

  • 3. Using the TBAg/PHA ratio in the T-SPOT(®).TB assay to distinguish TB disease from LTBI in an endemic area.
    Wang F; Hou HY; Wu SJ; Zhu Q; Huang M; Yin B; Huang J; Pan YY; Mao L; Sun ZY
    Int J Tuberc Lung Dis; 2016 Apr; 20(4):487-93. PubMed ID: 26970158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of the TBAg/PHA ratio in the diagnosis of active TB disease in immunocompromised patients.
    Bosco MJ; Hou H; Mao L; Wu X; Ramroop KD; Lu Y; Mao L; Zhou Y; Sun Z; Wang F
    Int J Infect Dis; 2017 Jun; 59():55-60. PubMed ID: 28392318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of mean spot sizes of ESAT-6 spot-forming cells and modified tuberculosis-specific antigen/phytohemagglutinin ratio of T-SPOT.TB assay in distinguishing between active tuberculosis and latent tuberculosis infection.
    Luo Y; Tang G; Lin Q; Mao L; Xue Y; Yuan X; Ouyang R; Wu S; Yu J; Zhou Y; Liu W; Hou H; Wang F; Sun Z
    J Infect; 2020 Jul; 81(1):81-89. PubMed ID: 32360883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of TBAg/PHA ratio in distinguishing tuberculoma from cancer in solitary pulmonary nodule or mass.
    Wang F; Hou H; Zhou H; Wu S; Mao L; Huang M; Yin B; Huang J; Sun Z
    Clin Respir J; 2018 Mar; 12(3):1174-1181. PubMed ID: 28488310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination of Xpert MTB/RIF and TBAg/PHA Ratio for Prompt Diagnosis of Active Tuberculosis: A Two-Center Prospective Cohort Study.
    Wang F; Liu K; Peng J; Luo Y; Tang G; Lin Q; Hou H; Liu W; Wang J; Fang Z; Kuang H; Sun Z
    Front Med (Lausanne); 2020; 7():119. PubMed ID: 32351964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Use of TB-Specific Antigen/Phytohemagglutinin Ratio for Diagnosis and Treatment Monitoring of Extrapulmonary Tuberculosis.
    Wang F; Yu J; Zhou Y; Luo Y; Wu S; Huang M; Yin B; Huang J; Mao L; Sun Z
    Front Immunol; 2018; 9():1047. PubMed ID: 29868010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination of HLA-DR on
    Luo Y; Xue Y; Tang G; Lin Q; Song H; Liu W; Yin B; Huang J; Wei W; Mao L; Wang F; Sun Z
    Front Immunol; 2021; 12():761209. PubMed ID: 34858413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of prealbumin and tuberculosis-specific antigen/phytohemagglutinin ratio for discriminating active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Yuan X; Lin Q; Tang G; Mao L; Song H; Wang F; Sun Z
    Int J Clin Pract; 2021 Apr; 75(4):e13831. PubMed ID: 33175465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A combination of iron metabolism indexes and tuberculosis-specific antigen/phytohemagglutinin ratio for distinguishing active tuberculosis from latent tuberculosis infection.
    Luo Y; Xue Y; Lin Q; Tang G; Yuan X; Mao L; Song H; Wang F; Sun Z
    Int J Infect Dis; 2020 Aug; 97():190-196. PubMed ID: 32497795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of LAMP, GeneXpert, Mycobacterial Culture, Smear Microscopy, TSPOT.TB, TBAg/PHA Ratio for Diagnosis of Pulmonary Tuberculosis.
    Deng Y; Duan YF; Gao SP; Wang JM
    Curr Med Sci; 2021 Oct; 41(5):1023-1028. PubMed ID: 34476662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using TBAg/PHA Ratio for Monitoring TB Treatment: A Prospective Multicenter Study.
    Wang X; Li M; Liu G; Wu X; Wan R; Hou H; Wu S; Sun Z; Kuang H; Wang F
    J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of gamma interferon release assays using Mycobacterium tuberculosis antigens for diagnosis of latent and active tuberculosis in Mycobacterium bovis BCG-vaccinated populations.
    Zhang S; Shao L; Mo L; Chen J; Wang F; Meng C; Zhong M; Qiu L; Wu M; Weng X; Zhang W
    Clin Vaccine Immunol; 2010 Dec; 17(12):1985-90. PubMed ID: 20943878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the characteristics of the enzyme-linked immunospot assay for diagnosis of active tuberculosis in China.
    Wang L; Yu Y; Chen W; Feng J; Wang J; Zhao H; Ma L; Yang B; Ma Y; Dang P
    Clin Vaccine Immunol; 2015 May; 22(5):510-5. PubMed ID: 25739918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel biomarker based on lymphocyte count, albumin level, and TBAg/PHA ratio for differentiation between active and latent tuberculosis infection in Japan.
    Katakura S; Kobayashi N; Hashimoto H; Kamimaki C; Tanaka K; Kubo S; Nakashima K; Teranishi S; Watanabe K; Hara Y; Yamamoto M; Kudo M; Piao H; Kaneko T
    Tuberculosis (Edinb); 2020 Dec; 125():101992. PubMed ID: 32957053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymphocyte Non-Specific Function Detection Facilitating the Stratification of
    Luo Y; Xue Y; Cai Y; Lin Q; Tang G; Song H; Liu W; Mao L; Yuan X; Zhou Y; Liu W; Wu S; Sun Z; Wang F
    Front Immunol; 2021; 12():641378. PubMed ID: 33953714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-Gamma Release Assay is Not Appropriate for the Diagnosis of Active Tuberculosis in High-Burden Tuberculosis Settings: A Retrospective Multicenter Investigation.
    Kang WL; Wang GR; Wu MY; Yang KY; Er-Tai A; Wu SC; Geng SJ; Li ZH; Li MW; Li L; Tang SJ
    Chin Med J (Engl); 2018 Feb; 131(3):268-275. PubMed ID: 29363640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance Evaluation of IGRA-ELISA and T-SPOT.TB for Diagnosing Tuberculosis Infection.
    Zhu M; Zhu Z; Yang J; Hu K
    Clin Lab; 2019 Aug; 65(8):. PubMed ID: 31414740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.